United States · FDA National Drug Code directory
ETOPOSIDE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 83270-451_5744cb93-0a8c-19ca-e063-6294a90aecd6
- Product NDC
- 83270-451
- Form
- CAPSULE
- Composition / generic term
- ETOPOSIDE
- Labeler
- Onesource Specialty Pharma Limited
- Marketing category
- NDA
- Marketing start / end (source format)
- 20260529
- Source listing expiry
- 20271231
Source-listed ingredients
- ETOPOSIDE — 50 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 20 CAPSULE in 1 CARTON (83270-451-05) · 83270-451-05
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →